Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Rose 8.4% in First Half of 2022

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 51.4 million yuan in the first half of 2022, up 8.4% year-on-year.

Meanwhile, the company posted 461.8 million yuan in revenue, up 19.4% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 777.6 million yuan in total liabilities, with a liability-to-asset ratio of 31.7%.